At the debut trade on Friday August 21 Kymera Therapeutics showed 66.30% raise and closed at $33.26 per share. The day before the company placed its shares in an IPO at a price $20 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей